The Financial Express

WHO approves Sinovac COVID-19 vaccine for emergency use

| Updated: June 02, 2021 14:30:38

-Reuters file photo -Reuters file photo

The World Health Organization (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use, the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.

Emergency listing of WHO is a signal to national regulators on a product's safety and efficacy.

It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems due to India's suspension of vaccine exports.

In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later. There was no upper age limit as data suggested it is likely to have a protective effect in older people.

Share if you like